Portfolio company
Applied Cognition
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops non-invasive glymphatic system monitoring platforms and drug therapies for patients with neurological disorders like Alzheimer's and Parkinson's.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Sinaptica Therapeutics
The company develops non-invasive neuromodulation systems for Alzheimer's patients to slow cognitive decline using personalized brain stimulation technology.
Cogniguard
This company develops non-invasive vagus nerve stimulation medical devices to treat patients with Alzheimer's disease and mild cognitive impairment.
Cognito Tx
This company develops non-invasive wearable devices using light and sound stimulation to treat patients with Alzheimer's and other neurodegenerative diseases.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
Cognoptix
This company develops a non-invasive eye scanning system to detect Alzheimer's disease for clinicians and pharmaceutical partners.
Neuromedical
This company develops non-invasive neuromodulation devices to treat cognitive impairments and Alzheimer's disease for healthcare professionals and patients.
Leucadia Therapeutics
This company develops an implantable medical device to restore cerebrospinal fluid flow for patients with Alzheimer's disease and mild cognitive impairment.
Polku Therapeutics Oy
This company develops small molecule therapies targeting neurodegenerative diseases for patients with conditions such as dementia, Parkinson's and traumatic brain injury.
